Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
40.56
-0.29 (-0.71%)
Oct 29, 2025, 4:00 PM EDT
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $280.65 billion as of October 30, 2025. Its market cap has increased by 11.19% in one year.
Market Cap
280.65B
Enterprise Value
314.54B
Revenue
79.83B
Ranking
n/a
PE Ratio
23.67
Stock Price
$40.56
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 280.65B, an increase of 3,104.29%. That is a compound annual growth rate of 10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 280.65B | 24.06% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | 299.05B | 8.13% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 668.66M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 337.25M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |